Canadian investor Brookfield is in advanced discussions to invest up to $1 billion through multiple tranches in Avaada Ventures Pvt Ltd (AVPL), parent entity of Avaada Group. The first tranche of $400 million has been paid out. As programs scale up, the remaining $600 million will be allocated depending on performance-related milestones. Upon completion...
Tim Hortons Debuts in India, Localizes Menu
Ontario, Canada-based Tim Hortons launched two new branches in Delhi NCR on August 11. In India, Tim Hortons' joint venture entity is controlled by Apparel Group and Gateway Partners. This iconic Canadian chain of restaurants known all over the world for its signature coffee, food, and beverages, customized its menu...
U.S., India, 16 Allies Strengthen Supply Chains
U.S. Secretary of State Antony Blinken and Commerce Secretary Gina Raimondo co-hosted the Supply Chain Ministerial Forum virtually on July 19-20. A partnership was formed of 18 economies: the U.S. EU, Australia, Brazil, Canada, Congo, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, South Korea, Singapore, Spain and the U.K....
Germany Approves Bharat Biotech’s COVAXIN for Travel
German Ambassador to India and Bhutan, Walter J Lindner, announced that the government of Germany recognized WHO-listed Bharat Biotech's Covid vaccine, COVAXIN, for travel to the country starting June 1. In November last year the World Health Organization issued an emergency use listing for Covaxin, adding to a growing portfolio...
Washington Galvanizes as India Battles Covid-19 Tsunami
On April 6, 2020 , as the United States was pummeled by the Covid-19 pandemic, Time Magazine lamented how India had blocked exports of a malaria drug that held potential to treat novel coronavirus patients. The President of the United States tweeted asking India for help and within just six...
India’s Own Covid-19 Vaccine is 81 Percent Effective
Yesterday, Hyderabad-based Bharat Biotech published interim results from the Phase 3 trial of it Covid-19 vaccine, branded as Covaxin. 25,8000 subjects participated in the trial. The trial found 43 cases of COVID-19 patients who showed symptoms ranging from mild to moderate and severe, and of the total cases, 36 were from...